Jeremy Blavier

Jeremy Blavier

Auto-generated profile, based on publicly available information

Jeremy Blavier

Laboratory of Viral Interactomes, Interdisciplinary Cluster for Applied Genoproteomics (GIGA)-Molecular Biology of Diseases, University of Liège, 4000, Liège, Belgium

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2024 in Molecular Systems Biology
Verified
Journal Article
Open access
PTPhilipp Trepte
Philipp Trepte
CSChristopher Secker
Christopher Secker
JOJulien Olivet
Julien Olivet
JBJeremy Blavier
Jeremy Blavier
SKSimona Kostova
Simona Kostova
EWErich E Wanker
Erich E Wanker
Protein–protein interactions (PPIs) offer great opportunities to expand the druggable proteome and therapeutically tackle various diseases, but remain challenging targets for drug discovery. Here, we provide a comprehensive pipeline that combines experimental and computational tools to identify and validate PPI targets and perform early-stage drug discovery. We have developed a machine learning approach that prioritizes interactions by analyzing quantitative data from binary PPI assays or AlphaFold-Multimer predictions. Using the quantitative assay LuTHy together with our machine learning algorithm, we identified high-confidence interactions among SARS-CoV-2 proteins for which we predicted three-dimensional structures using AlphaFold-Multimer. We employed VirtualFlow to target the contact interface of the NSP10-NSP16 SARS-CoV-2 methyltransferase complex by ultra-large virtual drug screening. Thereby, we identified a compound that binds to NSP10 and inhibits its interaction with NSP16, while also disrupting the methyltransferase activity of the complex, and SARS-CoV-2 replication. Overall, this pipeline will help to prioritize PPI targets to accelerate the discovery of early-stage drug candidates targeting protein complexes and pathways.

1 December 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Thanigaimalai PillaiyarThanigaimalai Pillaiyar
Thanigaimalai Pillaiyar
FRFrancesca Rosato
Francesca Rosato
MWMonika Wozniak
Monika Wozniak
JBJeremy Blavier
Jeremy Blavier
MCMaëlle Charles
Maëlle Charles
JHJulien Hanson
Julien Hanson

20 July 2023 in Antiviral Research
Verified
Journal Article
Closed access
SMSibusiso B. Maseko
Sibusiso B. Maseko
YBYasmine Brammerloo
Yasmine Brammerloo
IMInge Van Molle
Inge Van Molle
ASAdrià Sogues
Adrià Sogues
CMCharlotte Martin
Charlotte Martin
JTJean-Claude Twizere
Jean-Claude Twizere